As a Free StocksGuide user, you can view scores for all 7,040 stocks worldwide.
8 Analysts have issued a Xtant Medical forecast:
8 Analysts have issued a Xtant Medical forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | 128 128 |
15%
15%
|
|
| Gross Profit | 77 77 |
12%
12%
|
|
| EBITDA | 4.49 4.49 |
126%
126%
|
|
| EBIT (Operating Income) EBIT | 0.03 0.03 |
101%
101%
|
|
| Net Profit | -4.58 -4.58 |
38%
38%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. The company is headquartered in Belgrade Montana, Montana and currently employs 217 full-time employees. The company went IPO on 2010-06-30. The firm is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. The company offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.
| Head office | United States |
| Employees | 225 |
| Website | xtantmedical.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


